Polaryx Therapeutics, Inc.
PLYX
$2.08
$0.062.97%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/1/2026
-
TipRanks
9/1/2026
-
Globe Newswire
8/25/2026
-
Globe Newswire
8/16/2026
-
Simply Wall St
8/13/2026
-
MarketBeat
8/13/2026
-
MarketBeat
7/17/2026
-
The Cerbat Gem
7/17/2026
-
TipRanks
7/13/2026
-
MarketBeat
7/12/2026
-
MarketBeat
5/28/2026
-
TipRanks Financial Blog
5/28/2026
-
Globe Newswire
5/14/2026
-
Globe Newswire
4/23/2026
-
Globe Newswire
4/21/2026
-
Globe Newswire
4/15/2026
-
Globe Newswire
4/15/2026
-
MarketBeat
4/1/2026
-
Globe Newswire
3/21/2026
-
MarketBeat
3/18/2026
-
TipRanks Financial Blog
3/17/2026
-
Globe Newswire
3/12/2026
-
TipRanks Financial Blog
3/12/2026
-
The Fly
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Sep 14 and 18 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
201 940 7236
Address
South Tower
140 E Ridgewood Avenue
Suite 415
Paramus, NJ 07652
140 E Ridgewood Avenue
Suite 415
Paramus, NJ 07652
Country
Year Founded
Business Description
Sector
Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal...
more